Breaking News Instant updates and real-time market news.

2022-09-01 11:54:08 LQDA Liquidia $4.67 / -1.12 (-19.34%) , UTHR United Therapeutics $226.68 / -0.04 (-0.02%) 11:54 09/01/22 09/01 11:54 09/01/22 11:54	Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright H.C. Wainwright analyst Andrew Fein presented his thoughts on the implications and expectations for both Liquidia (LQDA) and United Therapeutics (UTHR) following the Hatch-Waxman district court decision, stating that the district court ruling on the '793 patent "was a setback," but adding that Liquidia already won on the '793 patent in the IPR decision, which he sees "offering a clear path forward for appeals." In his view, the main conclusions from the announced Hatch-Waxman decision specifically determined that the asserted claims of the '066 patent were either invalid or not infringed, favoring Liquidia, and the asserted claims of the '793 patent were valid and infringed, favoring United "at this stage." The appeal process could be expected to take upwards of 14-18 months, said Fein, who acknowledges that in the scenario where the '793 patent is ultimately determined to remain intact despite appeals, final Yutrepia approval could be pushed to expiration of the '793 patent in May 2027. He maintains a Buy rating and $16 price target on Liquidia shares. LQDA Liquidia $4.67 / -1.12 (-19.34%) UTHR United Therapeutics $226.68 / -0.04 (-0.02%)	06 Sep 16 Sep 15 Apr

2022-09-01 11:54:08

LQDA

Liquidia

$4.67 / -1.12 (-19.34%)

, UTHR

United Therapeutics

$226.68 / -0.04 (-0.02%)

11:54

09/01/22

09/01

11:54

09/01/22

11:54

Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright

H.C. Wainwright analyst Andrew Fein presented his thoughts on the implications and expectations for both Liquidia (LQDA) and United Therapeutics (UTHR) following the Hatch-Waxman district court decision, stating that the district court ruling on the '793 patent "was a setback," but adding that Liquidia already won on the '793 patent in the IPR decision, which he sees "offering a clear path forward for appeals." In his view, the main conclusions from the announced Hatch-Waxman decision specifically determined that the asserted claims of the '066 patent were either invalid or not infringed, favoring Liquidia, and the asserted claims of the '793 patent were valid and infringed, favoring United "at this stage." The appeal process could be expected to take upwards of 14-18 months, said Fein, who acknowledges that in the scenario where the '793 patent is ultimately determined to remain intact despite appeals, final Yutrepia approval could be pushed to expiration of the '793 patent in May 2027. He maintains a Buy rating and $16 price target on Liquidia shares.

LQDA

Liquidia

$4.67 / -1.12 (-19.34%)

UTHR

United Therapeutics

$226.68 / -0.04 (-0.02%)

06
Sep
16
Sep

15
Apr

OTHER BREAKING NEWS FROM THE FLY

Earnings	Goodyear Tire reports Q4 adjusted EPS 7c, consensus 6c » 16:21 02/08/23 02/08 16:21 02/08/23 16:21 GT Goodyear Tire $11.10 / -0.415 (-3.60%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GT Goodyear Tire $11.10 / -0.415 (-3.60%) 01/27/23 Goodyear Tire announces cost savings plan, plans to reduce staff by 5% 12/14/22 Goodyear Tire appoints Christina Zamarro as CFO 12/01/22 Goodyear Tire, Nascar enter new multiyear agreement for tires 11/08/22 Goodyear Tire, Drive TLV announce partnership GT Goodyear Tire $11.10 / -0.415 (-3.60%) 01/30/23 Exane BNP Paribas Goodyear Tire downgraded to Underperform from Neutral at Exane BNP Paribas 01/19/23 Deutsche Bank Deutsche Bank initiates Sell catalyst call on Goodyear Tire 11/29/22 Argus Goodyear Tire cut to Hold at Argus on EMEA weakness, rising costs 11/29/22 Argus Goodyear Tire downgraded to Hold from Buy at Argus GT Goodyear Tire $11.10 / -0.415 (-3.60%) 10/31/22 Goodyear Tire reports Q3 adjusted EPS 40c, consensus 54c GT Goodyear Tire $11.10 / -0.415 (-3.60%) 01/25/23 DOJ probing Goodyear Tire's handling of recalled tire, WSJ reports GT Goodyear Tire $11.10 / -0.415 (-3.60%) 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 11/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/01/22 What You Missed On Wall Street On Tuesday 02/09/23 Goodyear Tire - GT GT Goodyear Tire $11.10 / -0.415 (-3.60%) 13:15 Today Goodyear Tire put volume heavy and directionally bearish 01/18/23 Goodyear Tire put volume heavy and directionally bearish 11/16/22 Goodyear Tire put volume heavy and directionally bearish 10/31/22 Goodyear Tire options imply 8.2% move in share price post-earnings
Earnings	Equitable Holdings reports Q4 adjusted EPS $1.11, consensus $1.26 » 16:21 02/08/23 02/08 16:21 02/08/23 16:21 EQH Equitable Holdings $32.75 / +0.29 (+0.89%) Reports Q4 revenue $1.9B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EQH Equitable Holdings $32.75 / +0.29 (+0.89%) 08/17/22 Equitable Holdings acquires Penn Investment Advisors EQH Equitable Holdings $32.75 / +0.29 (+0.89%) 06:31 Today Raymond James Equitable Holdings initiated with a Market Perform at Raymond James 12/09/22 Jefferies Equitable Holdings downgraded to Hold from Buy at Jefferies 12/06/22 RBC Capital Equitable Holdings cut to Sector Perform at RBC Capital on valuation 12/06/22 RBC Capital Equitable Holdings downgraded to Sector Perform from Outperform at RBC Capital EQH Equitable Holdings $32.75 / +0.29 (+0.89%) 11/02/22 Equitable Holdings reports Q3 EPS $1.28, consensus $1.10 02/09/23 Equitable Holdings - EQH
Earnings	Envista sees FY23 core sales growth low-single digits, consensus $2.68B » 16:21 02/08/23 02/08 16:21 02/08/23 16:21 NVST Envista $40.68 / -0.86 (-2.07%) "Despite the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NVST Envista $40.68 / -0.86 (-2.07%) 11/30/22 Envista seeing 'significant slowdown' in China in recent weeks 09/13/22 Envista announces data for NXP800 in a preclinical xenograft model NVST Envista $40.68 / -0.86 (-2.07%) 02/06/23 Piper Sandler Envista price target raised to $46 from $42 at Piper Sandler 11/04/22 Piper Sandler Envista price target lowered to $44 from $46 at Piper Sandler 08/29/22 Piper Sandler Envista upgraded to Overweight from Neutral at Piper Sandler 08/04/22 Piper Sandler Envista price target lowered to $40 from $43 at Piper Sandler NVST Envista $40.68 / -0.86 (-2.07%) 16:19 Today Envista reports Q4 adjusted EPS 52c, consensus 49c 11/03/22 Envista reports Q3 adjusted EPS 47c, consensus 47c NVST Envista $40.68 / -0.86 (-2.07%) 08/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 17:00 Today Envista - NVST
Hot Stocks	RenaissanceRe raises quarterly dividend to 38c per share from 37c » 16:21 02/08/23 02/08 16:21 02/08/23 16:21 RNR RenaissanceRe $216.96 / +1.545 (+0.72%) The dividend is payable… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RNR RenaissanceRe $216.96 / +1.545 (+0.72%) 10/19/22 RenaissanceRe sees $650M net negative impact on Q3 from catastrophe events RNR RenaissanceRe $216.96 / +1.545 (+0.72%) 02/02/23 Wells Fargo RenaissanceRe price target raised to $245 from $234 at Wells Fargo 01/19/23 BMO Capital RenaissanceRe initiated with a Market Perform at BMO Capital 12/30/22 Keefe Bruyette Keefe says Guy Carpenter news positive for catastrophe reinsurers 11/03/22 Wells Fargo RenaissanceRe price target raised to $184 from $171 at Wells Fargo RNR RenaissanceRe $216.96 / +1.545 (+0.72%) 01/31/23 RenaissanceRe reports Q4 operating EPS $7.33, consensus $6.40 11/01/22 RenaissanceRe reports Q3 operating EPS ($9.27), consensus ($8.31)
Earnings	Regional Management reports Q4 adjusted EPS 54c, consensus 73c » 16:20 02/08/23 02/08 16:20 02/08/23 16:20 RM Regional Management $36.61 / -0.09 (-0.25%) Reports Q4 revenue $132M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RM Regional Management $36.61 / -0.09 (-0.25%) 12/20/22 Regional Management expands operations to Idaho 09/13/22 Regional Management expands operations to Louisiana RM Regional Management $36.61 / -0.09 (-0.25%) 01/27/23 BMO Capital World Acceptance price target lowered to $32 from $46 at BMO Capital 08/05/22 BMO Capital Regional Management price target lowered to $52 from $58 at BMO Capital 07/11/22 Keefe Bruyette Regional Management price target lowered to $41 from $53 at Keefe Bruyette RM Regional Management $36.61 / -0.09 (-0.25%) 11/01/22 Regional Management reports Q3 EPS $1.06, consensus 90c 17:00 Today Regional Management - RM
Earnings	23andMe sees FY23 revenue $290M-$300M, consensus $276.59M » 16:20 02/08/23 02/08 16:20 02/08/23 16:20 ME 23andMe $2.53 / +0.01 (+0.40%) Sees full year 2023… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ME 23andMe $2.53 / +0.01 (+0.40%) 11/07/22 23andMe presents poster for expansion chohorts for 23ME-00610 10/27/22 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1 09/19/22 23andMe appoints Daniel Chu as CPO 08/19/22 23andMe CFO Steven Schoch to step down ME 23andMe $2.53 / +0.01 (+0.40%) 11/28/22 Berenberg Berenberg starts 'well-positioned' 23andMe with a Buy 11/28/22 Berenberg 23andMe initiated with a Buy at Berenberg 09/22/22 Cowen 23andMe initiated with Outperform, $6 target at Cowen 09/22/22 Cowen 23andMe initiated with an Outperform at Cowen ME 23andMe $2.53 / +0.01 (+0.40%) 16:18 Today 23andMe reports Q3 EPS (20c), consensus (19c) 11/07/22 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M 11/07/22 23andMe reports Q2 EPS (15c), consensus (17c) ME 23andMe $2.53 / +0.01 (+0.40%) 11/29/22 Fly Intel: Pre-market Movers 11/07/22 Fly Intel: After-Hours Movers 08/19/22 What You Missed On Wall Street On Friday 08/19/22 What You Missed On Wall Street This Morning 16:30 Today 23andMe - ME
Earnings	PHX Minerals reports Q4 adjusted EPS 7c, consensus 15c » 16:20 02/08/23 02/08 16:20 02/08/23 16:20 PHX PHX Minerals $3.31 / -0.045 (-1.34%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PHX PHX Minerals $3.31 / -0.045 (-1.34%) 12/13/22 PHX Minerals raises dividend 12.5% to 2.25c 10/12/22 PHX Minerals completes divestiture, additional mineral acquisitions PHX PHX Minerals $3.31 / -0.045 (-1.34%) 10/03/22 Northland PHX Minerals assumed with an Outperform at Northland PHX PHX Minerals $3.31 / -0.045 (-1.34%) 12/13/22 PHX Minerals reports Q4 EPS 26c, consensus 18c PHX PHX Minerals $3.31 / -0.045 (-1.34%) 12/14/22 What You Missed On Wall Street On Wednesday 12/14/22 What You Missed On Wall Street This Morning 12/13/22 Fly Intel: After-Hours Movers 02/09/23 PHX Minerals - PHX 03/06/23 PHX Minerals Inc
Earnings	Equity Commonwealth reports Q4 FFO 21c, one estimate 13c » 16:20 02/08/23 02/08 16:20 02/08/23 16:20 EQC Equity Commonwealth $25.15 / -0.15 (-0.59%) Reports Q4 revenue $15.8M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events EQC Equity Commonwealth $25.15 / -0.15 (-0.59%) 09/08/22 Equity Commonwealth announces $1.00 per share special dividend EQC Equity Commonwealth $25.15 / -0.15 (-0.59%) 10/25/22 Equity Commonwealth reports Q3 FFO 13c, one estimate 5c 02/09/23 Equity Commonwealth - EQC
Recommendations	Fox Corp. price target raised to $44 from $40 at Wells Fargo » 16:20 02/08/23 02/08 16:20 02/08/23 16:20 FOXA Fox Corp. $35.55 / +1.49 (+4.37%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FOXA Fox Corp. $35.55 / +1.49 (+4.37%) 08:07 Today Fox Corp. announces $1B accelerated share repurchase plan 08:01 Today Fox Corp. announces incremental $3B stock repurchase authorization 01/31/23 Tubi signs content deal with Warner Bros. Discovery 01/24/23 Irenic Capital comments on withdrawal of proposal to combine News Corp, Fox FOXA Fox Corp. $35.55 / +1.49 (+4.37%) 01/31/23 Morgan Stanley Fox Corp. resumed with an Equal Weight at Morgan Stanley 01/25/23 Loop Capital Fox upgraded to Buy with $40 price target at Loop Capital 01/25/23 Loop Capital Loop upgrades News Corp. to Buy on ending of Fox tie-up 01/25/23 Loop Capital Fox Corp. upgraded to Buy from Hold at Loop Capital FOXA Fox Corp. $35.55 / +1.49 (+4.37%) 08:00 Today Fox Corp. reports Q2 adjusted EPS 48c, consensus 48c 02/07/23 Notable companies reporting before tomorrow's open 02/07/23 Notable companies reporting before tomorrow's open 11/01/22 Fox Corp. reports Q1 adjusted EPS $1.21, consensus $1.14 FOXA Fox Corp. $35.55 / +1.49 (+4.37%) 01/31/23 Warner Bros. Discovery in deals with Roku, Tubi for FAST channels, Reuters says 01/24/23 News Corp. in discussions to sell 80% Move stake to CoStar, FT reports 01/13/23 YouTube testing new hub of free, ad-supported streaming channels, WSJ reports 01/04/23 Fox Corp., News Corp. renew office leases in Manhattan, WSJ reports FOXA Fox Corp. $35.55 / +1.49 (+4.37%) 01/31/23 What You Missed On Wall Street On Tuesday 01/31/23 What You Missed On Wall Street This Morning 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/23 What You Missed On Wall Street On Wednesday 08:30 Today Fox Corp. - FOXA FOXA Fox Corp. $35.55 / +1.49 (+4.37%) 09:55 Today Early notable gainers among liquid option names on February 8th 01/25/23 Early notable gainers among liquid option names on January 25th
Options	Closing CBOE SPX and VIX Index summary for February 8th » 16:20 02/08/23 02/08 16:20 02/08/23 16:20 VIX Volatility Index S&P 500 Options / + The CBOE Volatility Index… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Options VIX Volatility Index S&P 500 Options / + 02/07/23 Closing CBOE SPX and VIX Index summary for February 7th 02/06/23 Closing CBOE SPX and VIX Index summary for February 6th 02/03/23 Closing CBOE SPX and VIX Index summary for February 3rd 02/02/23 Closing CBOE SPX and VIX Index summary for February 2nd

Earnings	Envista reports Q4 adjusted EPS 52c, consensus 49c » 16:19 02/08/23 02/08 16:19 02/08/23 16:19 NVST Envista $40.68 / -0.86 (-2.07%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NVST Envista $40.68 / -0.86 (-2.07%) 11/30/22 Envista seeing 'significant slowdown' in China in recent weeks 09/13/22 Envista announces data for NXP800 in a preclinical xenograft model NVST Envista $40.68 / -0.86 (-2.07%) 02/06/23 Piper Sandler Envista price target raised to $46 from $42 at Piper Sandler 11/04/22 Piper Sandler Envista price target lowered to $44 from $46 at Piper Sandler 08/29/22 Piper Sandler Envista upgraded to Overweight from Neutral at Piper Sandler 08/04/22 Piper Sandler Envista price target lowered to $40 from $43 at Piper Sandler NVST Envista $40.68 / -0.86 (-2.07%) 11/03/22 Envista reports Q3 adjusted EPS 47c, consensus 47c NVST Envista $40.68 / -0.86 (-2.07%) 08/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 17:00 Today Envista - NVST
Earnings	Molina Healthcare sees FY23 adjusted EPS at least $19.75, consensus $19.59 » 16:19 02/08/23 02/08 16:19 02/08/23 16:19 MOH Molina Healthcare $307.50 / +5.02 (+1.66%) Sees FY23 revenue $33B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 01/03/23 Molina Healthcare to double California revenue with Medi-Cal contracts in 2024 12/29/22 Molina Healthcare to record $200M impairment charge in Q4 on leased space 09/26/22 Molina Healthcare selected for Nebraska Medicaid program 08/31/22 Molina Healthcare wins Iowa Medicaid contract MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan 01/04/23 Barclays Molina Healthcare price target lowered to $375 from $400 at Barclays 12/13/22 BofA Molina Healthcare upgraded to Neutral at BofA on 'high confidence' in EPS growth 12/13/22 BofA Molina Healthcare upgraded to Neutral from Underperform at BofA MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 16:19 Today Molina Healthcare reports Q4 adjusted EPS $4.10, consensus $4.02 10/26/22 Molina Healthcare raises FY22 adjusted EPS view to at least $17.75 from $17.60 10/26/22 Molina Healthcare reports Q3 adjusted EPS $4.36, consensus $4.21 MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 09/23/22 Nebraska picks two current, one new Medicaid health plan provider, OWH reports 09/23/22 UnitedHealth, Molina, Centene win Medicaid contracts in Nebraska, Bloomberg says 08/18/22 White House plans for end of COVID-19 vaccine coverage, WSJ reports MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/18/22 COVID vaccine makers under pressure as White House plans to end coverage 02/09/23 Molina Healthcare - MOH MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 08/26/22 Early notable gainers among liquid option names on August 26th
Earnings	AvalonBay sees FY23 core FFO $10.07-$10.56, consensus $10.51 16:19 02/08/23 02/08 16:19 02/08/23 16:19 AVB AvalonBay $181.70 / +2.075 (+1.16%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events AVB AvalonBay $181.70 / +2.075 (+1.16%) 16:18 Today AvalonBay announces 3.8% increase to quarterly dividend to $1.65 per share 02/05/23 Fly Intel: Top five weekend stock stories AVB AvalonBay $181.70 / +2.075 (+1.16%) 01/17/23 Truist AvalonBay upgraded to Buy from Hold at Truist 01/04/23 Deutsche Bank Deutsche downgrades six REITs to Hold, urges caution into 2023 01/04/23 Deutsche Bank AvalonBay downgraded to Hold from Buy at Deutsche Bank 12/16/22 JPMorgan AvalonBay downgraded to Underweight from Neutral at JPMorgan AVB AvalonBay $181.70 / +2.075 (+1.16%) 16:19 Today AvalonBay sees Q1 core FFO $2.47-$2.57, consensus $2.59 16:17 Today AvalonBay reports Q4 core FFO $2.59, consensus $2.58 11/03/22 AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96 11/03/22 AvalonBay sees Q4 core FFO $2.55-$2.65 07 Apr AVB AvalonBay $181.70 / +2.075 (+1.16%) 02/04/23 Housing downturn could fuel gains for residential REITs, Barron's says AVB AvalonBay $181.70 / +2.075 (+1.16%) 12/16/22 What You Missed On Wall Street On Friday 12/16/22 What You Missed On Wall Street This Morning 12/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/24/22 What You Missed On Wall Street On Wednesday 02/09/23 AvalonBay - AVB
Earnings	AvalonBay sees Q1 core FFO $2.47-$2.57, consensus $2.59 16:19 02/08/23 02/08 16:19 02/08/23 16:19 AVB AvalonBay $181.70 / +2.075 (+1.16%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events AVB AvalonBay $181.70 / +2.075 (+1.16%) 16:18 Today AvalonBay announces 3.8% increase to quarterly dividend to $1.65 per share 02/05/23 Fly Intel: Top five weekend stock stories AVB AvalonBay $181.70 / +2.075 (+1.16%) 01/17/23 Truist AvalonBay upgraded to Buy from Hold at Truist 01/04/23 Deutsche Bank Deutsche downgrades six REITs to Hold, urges caution into 2023 01/04/23 Deutsche Bank AvalonBay downgraded to Hold from Buy at Deutsche Bank 12/16/22 JPMorgan AvalonBay downgraded to Underweight from Neutral at JPMorgan AVB AvalonBay $181.70 / +2.075 (+1.16%) 16:17 Today AvalonBay reports Q4 core FFO $2.59, consensus $2.58 11/03/22 AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96 11/03/22 AvalonBay sees Q4 core FFO $2.55-$2.65 11/03/22 AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53 07 Apr AVB AvalonBay $181.70 / +2.075 (+1.16%) 02/04/23 Housing downturn could fuel gains for residential REITs, Barron's says AVB AvalonBay $181.70 / +2.075 (+1.16%) 12/16/22 What You Missed On Wall Street On Friday 12/16/22 What You Missed On Wall Street This Morning 12/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/24/22 What You Missed On Wall Street On Wednesday 02/09/23 AvalonBay - AVB
Earnings	Molina Healthcare reports Q4 adjusted EPS $4.10, consensus $4.02 » 16:19 02/08/23 02/08 16:19 02/08/23 16:19 MOH Molina Healthcare $307.50 / +5.02 (+1.66%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 01/03/23 Molina Healthcare to double California revenue with Medi-Cal contracts in 2024 12/29/22 Molina Healthcare to record $200M impairment charge in Q4 on leased space 09/26/22 Molina Healthcare selected for Nebraska Medicaid program 08/31/22 Molina Healthcare wins Iowa Medicaid contract MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan 01/04/23 Barclays Molina Healthcare price target lowered to $375 from $400 at Barclays 12/13/22 BofA Molina Healthcare upgraded to Neutral at BofA on 'high confidence' in EPS growth 12/13/22 BofA Molina Healthcare upgraded to Neutral from Underperform at BofA MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 10/26/22 Molina Healthcare raises FY22 adjusted EPS view to at least $17.75 from $17.60 10/26/22 Molina Healthcare reports Q3 adjusted EPS $4.36, consensus $4.21 MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 09/23/22 Nebraska picks two current, one new Medicaid health plan provider, OWH reports 09/23/22 UnitedHealth, Molina, Centene win Medicaid contracts in Nebraska, Bloomberg says 08/18/22 White House plans for end of COVID-19 vaccine coverage, WSJ reports MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/18/22 COVID vaccine makers under pressure as White House plans to end coverage 02/09/23 Molina Healthcare - MOH MOH Molina Healthcare $307.50 / +5.02 (+1.66%) 08/26/22 Early notable gainers among liquid option names on August 26th
Earnings	Everest Re reports Q4 EPS $12.66, consensus $9.87 » 16:18 02/08/23 02/08 16:18 02/08/23 16:18 RE Everest Re $357.32 / +1.55 (+0.44%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RE Everest Re $357.32 / +1.55 (+0.44%) 01/05/23 Everest Re names Srini Maddineni chief information officer 10/19/22 Everest Re estimates pre-tax net catastrophe losses of $730M for Q3 RE Everest Re $357.32 / +1.55 (+0.44%) 02/02/23 Raymond James Everest Re initiated with an Outperform at Raymond James 02/01/23 Raymond James Everest Re initiated with an Outperform at Raymond James 01/19/23 BMO Capital Everest Re initiated with a Market Perform at BMO Capital 12/30/22 Keefe Bruyette Keefe says Guy Carpenter news positive for catastrophe reinsurers RE Everest Re $357.32 / +1.55 (+0.44%) 10/26/22 Everest Re reports Q3 operating EPS ($5.28), consensus ($5.51) RE Everest Re $357.32 / +1.55 (+0.44%) 02/02/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 Everest Re - RE
Hot Stocks	MGM Resorts CEO says 'strong momentum in our business' » 16:18 02/08/23 02/08 16:18 02/08/23 16:18 MGM MGM Resorts $41.46 / -0.53 (-1.26%) "We achieved our… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MGM MGM Resorts $41.46 / -0.53 (-1.26%) 16:17 Today MGM Resorts announces new $2B share repurchase program 02/01/23 Macau reports January casino revenue up 82.5% to 11.58B patacas 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 01/27/23 MGM Resorts, NFLPA launch events, hospitality partnership MGM MGM Resorts $41.46 / -0.53 (-1.26%) 01/06/23 Stifel MGM Resorts upgraded to Buy from Hold at Stifel 12/27/22 UBS Macau GGR could be lifted 'significantly' from early 2023, says UBS 12/05/22 Truist MGM Resorts upgraded to Buy at Truist amid returning activity at the Strip 12/05/22 Truist MGM Resorts upgraded to Buy from Hold at Truist MGM MGM Resorts $41.46 / -0.53 (-1.26%) 16:15 Today MGM Resorts reports Q4 adjusted EPS ($1.53), consensus ($1.36) 12:48 Today Notable companies reporting after market close 11/02/22 MGM Resorts reports Q3 adjusted EPS ($1.39), consensus 23c 11/02/22 Notable companies reporting after market close MGM MGM Resorts $41.46 / -0.53 (-1.26%) 12/03/22 World Cup is a score for betting stock Entain, Barron's says 11/21/22 China reports first Covid-19 deaths since May, WSJ reports 11/16/22 Security hole found at Global Payments by online poker pros, Poker.org says 11/11/22 China intends to ease some quarantine rules for travelers, ABC News reports MGM MGM Resorts $41.46 / -0.53 (-1.26%) 02/03/23 Bet On It: DraftKings layoffs could signal more emphasis on profitability 01/27/23 Bet On It: U.K. gambling authority says reform in the works 01/20/23 Bet On It: Kentucky lawmaker sees momentum towards sports betting legalization 01/13/23 Bet On It: PlayUp SPAC deal terminated 17:00 Today MGM Resorts - MGM MGM MGM Resorts $41.46 / -0.53 (-1.26%) 14:04 Today MGM Resorts options imply 4.8% move in share price post-earnings 01/30/23 MGM Resorts call volume above normal and directionally bullish 01/11/23 MGM Resorts put volume heavy and directionally bearish 12/28/22 MGM Resorts put volume heavy and directionally bearish
Earnings	23andMe reports Q3 EPS (20c), consensus (19c) » 16:18 02/08/23 02/08 16:18 02/08/23 16:18 ME 23andMe $2.53 / +0.01 (+0.40%) Reports Q3 revenue $67M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ME 23andMe $2.53 / +0.01 (+0.40%) 11/07/22 23andMe presents poster for expansion chohorts for 23ME-00610 10/27/22 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1 09/19/22 23andMe appoints Daniel Chu as CPO 08/19/22 23andMe CFO Steven Schoch to step down ME 23andMe $2.53 / +0.01 (+0.40%) 11/28/22 Berenberg Berenberg starts 'well-positioned' 23andMe with a Buy 11/28/22 Berenberg 23andMe initiated with a Buy at Berenberg 09/22/22 Cowen 23andMe initiated with Outperform, $6 target at Cowen 09/22/22 Cowen 23andMe initiated with an Outperform at Cowen ME 23andMe $2.53 / +0.01 (+0.40%) 11/07/22 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M 11/07/22 23andMe reports Q2 EPS (15c), consensus (17c) ME 23andMe $2.53 / +0.01 (+0.40%) 11/29/22 Fly Intel: Pre-market Movers 11/07/22 Fly Intel: After-Hours Movers 08/19/22 What You Missed On Wall Street On Friday 08/19/22 What You Missed On Wall Street This Morning 16:30 Today 23andMe - ME
Hot Stocks	AvalonBay announces 3.8% increase to quarterly dividend to $1.65 per share » 16:18 02/08/23 02/08 16:18 02/08/23 16:18 AVB AvalonBay $181.70 / +2.075 (+1.16%) The company's Board… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events AVB AvalonBay $181.70 / +2.075 (+1.16%) 02/05/23 Fly Intel: Top five weekend stock stories AVB AvalonBay $181.70 / +2.075 (+1.16%) 01/17/23 Truist AvalonBay upgraded to Buy from Hold at Truist 01/04/23 Deutsche Bank Deutsche downgrades six REITs to Hold, urges caution into 2023 01/04/23 Deutsche Bank AvalonBay downgraded to Hold from Buy at Deutsche Bank 12/16/22 JPMorgan AvalonBay downgraded to Underweight from Neutral at JPMorgan AVB AvalonBay $181.70 / +2.075 (+1.16%) 16:17 Today AvalonBay reports Q4 core FFO $2.59, consensus $2.58 11/03/22 AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96 11/03/22 AvalonBay sees Q4 core FFO $2.55-$2.65 11/03/22 AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53 07 Apr AVB AvalonBay $181.70 / +2.075 (+1.16%) 02/04/23 Housing downturn could fuel gains for residential REITs, Barron's says AVB AvalonBay $181.70 / +2.075 (+1.16%) 12/16/22 What You Missed On Wall Street On Friday 12/16/22 What You Missed On Wall Street This Morning 12/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/24/22 What You Missed On Wall Street On Wednesday 02/09/23 AvalonBay - AVB
Earnings	Two Harbors reports Q4 EPS ex-items 73c, consensus 53c » 16:18 02/08/23 02/08 16:18 02/08/23 16:18 TWO Two Harbors $17.21 / +0.135 (+0.79%) "Despite spread… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TWO Two Harbors $17.21 / +0.135 (+0.79%) 11/02/22 Two Harbors announced one-for-four reverse stock split 10/12/22 Two Harbors estimates book value per common share $4.09-$4.13 08/15/22 Two Harbors appoints Nicholas Letica as chief investment officer TWO Two Harbors $17.21 / +0.135 (+0.79%) 11/17/22 RBC Capital Two Harbors cut to Sector Perform at RBC Capital on risk of dividend cut 11/17/22 RBC Capital Two Harbors downgraded to Sector Perform from Outperform at RBC Capital 11/10/22 Barclays Two Harbors price target raised to $16 from $5 at Barclays 10/05/22 RBC Capital Two Harbors price target lowered to $4.50 from $5.50 at RBC Capital TWO Two Harbors $17.21 / +0.135 (+0.79%) 01/19/23 Two Harbors sees book value per common share at end of Q4 $17.70-$17.74 11/08/22 Two Harbors reports Q3 EPS 64c, consensus 79c 11/08/22 Two Harbors reports Q3 EPS 64c, consensus 79c 03 Feb TWO Two Harbors $17.21 / +0.135 (+0.79%) 02/03/23 What You Missed On Wall Street On Friday 02/03/23 What You Missed On Wall Street This Morning 02/09/23 Two Harbors - TWO TWO Two Harbors $17.21 / +0.135 (+0.79%) 11/03/22 Notable open interest changes for November 3rd

Earnings	Moelis reports Q4 adjusted EPS 33c, consensus 33c » 16:17 02/08/23 02/08 16:17 02/08/23 16:17 MC Moelis $47.06 / -0.63 (-1.32%) Reports Q4 GAAP revenues… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events MC Moelis $47.06 / -0.63 (-1.32%) 01/10/23 Goldman Sachs Moelis downgraded to Sell from Neutral at Goldman Sachs 01/02/23 Keefe Bruyette Moelis transferred with Underperform rating at Keefe Bruyette 01/02/23 Keefe Bruyette Evercore upgraded to Outperform from Market Perform at Keefe Bruyette 11/03/22 Keefe Bruyette Moelis downgraded to Underperform from Market Perform at Keefe Bruyette MC Moelis $47.06 / -0.63 (-1.32%) 11/02/22 Moelis reports Q3 adjusted EPS 37c, consensus 35c MC Moelis $47.06 / -0.63 (-1.32%) 12/07/22 What You Missed On Wall Street On Wednesday 09/23/22 What You Missed On Wall Street On Friday 09/23/22 What You Missed On Wall Street This Morning 08/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 17:00 Today Moelis - MC
Earnings	AvalonBay reports Q4 core FFO $2.59, consensus $2.58 » 16:17 02/08/23 02/08 16:17 02/08/23 16:17 AVB AvalonBay $181.70 / +2.075 (+1.16%) Same Store total revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events AVB AvalonBay $181.70 / +2.075 (+1.16%) 02/05/23 Fly Intel: Top five weekend stock stories AVB AvalonBay $181.70 / +2.075 (+1.16%) 01/17/23 Truist AvalonBay upgraded to Buy from Hold at Truist 01/04/23 Deutsche Bank Deutsche downgrades six REITs to Hold, urges caution into 2023 01/04/23 Deutsche Bank AvalonBay downgraded to Hold from Buy at Deutsche Bank 12/16/22 JPMorgan AvalonBay downgraded to Underweight from Neutral at JPMorgan AVB AvalonBay $181.70 / +2.075 (+1.16%) 11/03/22 AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96 11/03/22 AvalonBay sees Q4 core FFO $2.55-$2.65 11/03/22 AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53 07 Apr AVB AvalonBay $181.70 / +2.075 (+1.16%) 02/04/23 Housing downturn could fuel gains for residential REITs, Barron's says AVB AvalonBay $181.70 / +2.075 (+1.16%) 12/16/22 What You Missed On Wall Street On Friday 12/16/22 What You Missed On Wall Street This Morning 12/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/24/22 What You Missed On Wall Street On Wednesday 02/09/23 AvalonBay - AVB
Earnings	Impinj sees Q1 EPS 30c-36c, consensus 34c » 16:17 02/08/23 02/08 16:17 02/08/23 16:17 PI Impinj $125.08 / -4.215 (-3.26%) Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PI Impinj $125.08 / -4.215 (-3.26%) 08/23/22 Impinj CEO sells $923K in common stock PI Impinj $125.08 / -4.215 (-3.26%) 01/27/23 Piper Sandler Impinj price target raised to $140 from $120 at Piper Sandler 01/12/23 Jefferies Impinj price target raised to $137 from $112 at Jefferies 01/12/23 Needham Impinj price target raised to $130 from $120 at Needham 01/11/23 Lake Street Impinj price target raised to $132 from $109 at Lake Street PI Impinj $125.08 / -4.215 (-3.26%) 16:16 Today Impinj reports Q4 EPS 41c, consensus 40c 01/10/23 Impinj raises Q4 revenue view to over $76M from $71.5M-$73.5M 10/26/22 Impinj sees Q4 EPS 32c-37c, consensus 16c 10/26/22 Impinj reports Q3 EPS 34c, consensus 16c PI Impinj $125.08 / -4.215 (-3.26%) 01/10/23 Fly Intel: After-Hours Movers 03/12/23 35th Annual Roth Conference 17:00 Today Impinj - PI 03/01/23 Impinj
Hot Stocks	MGM Resorts announces new $2B share repurchase program 16:17 02/08/23 02/08 16:17 02/08/23 16:17 MGM MGM Resorts $41.46 / -0.53 (-1.26%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MGM MGM Resorts $41.46 / -0.53 (-1.26%) 02/01/23 Macau reports January casino revenue up 82.5% to 11.58B patacas 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 01/27/23 MGM Resorts, NFLPA launch events, hospitality partnership 01/26/23 BetMGM sees FY23 revenue $1.8B-$2B, expects to be EBITDA positive in second half MGM MGM Resorts $41.46 / -0.53 (-1.26%) 01/06/23 Stifel MGM Resorts upgraded to Buy from Hold at Stifel 12/27/22 UBS Macau GGR could be lifted 'significantly' from early 2023, says UBS 12/05/22 Truist MGM Resorts upgraded to Buy at Truist amid returning activity at the Strip 12/05/22 Truist MGM Resorts upgraded to Buy from Hold at Truist MGM MGM Resorts $41.46 / -0.53 (-1.26%) 16:15 Today MGM Resorts reports Q4 adjusted EPS ($1.53), consensus ($1.36) 12:48 Today Notable companies reporting after market close 11/02/22 MGM Resorts reports Q3 adjusted EPS ($1.39), consensus 23c 11/02/22 Notable companies reporting after market close MGM MGM Resorts $41.46 / -0.53 (-1.26%) 12/03/22 World Cup is a score for betting stock Entain, Barron's says 11/21/22 China reports first Covid-19 deaths since May, WSJ reports 11/16/22 Security hole found at Global Payments by online poker pros, Poker.org says 11/11/22 China intends to ease some quarantine rules for travelers, ABC News reports MGM MGM Resorts $41.46 / -0.53 (-1.26%) 02/03/23 Bet On It: DraftKings layoffs could signal more emphasis on profitability 01/27/23 Bet On It: U.K. gambling authority says reform in the works 01/20/23 Bet On It: Kentucky lawmaker sees momentum towards sports betting legalization 01/13/23 Bet On It: PlayUp SPAC deal terminated 17:00 Today MGM Resorts - MGM MGM MGM Resorts $41.46 / -0.53 (-1.26%) 14:04 Today MGM Resorts options imply 4.8% move in share price post-earnings 01/30/23 MGM Resorts call volume above normal and directionally bullish 01/11/23 MGM Resorts put volume heavy and directionally bearish 12/28/22 MGM Resorts put volume heavy and directionally bearish
Hot Stocks	Affirm sinks 18% to $13.02 after Q2 miss, outlook reduction 16:17 02/08/23 02/08 16:17 02/08/23 16:17 AFRM Affirm $15.99 / -1.22 (-7.09%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AFRM Affirm $15.99 / -1.22 (-7.09%) 16:16 Today Affirm cuts 2023 outlook amid macroeconomic headwinds 16:16 Today Affirm sees $77M-$83M in annualized cost savings 16:13 Today Affirm to reduce workforce by 19%, effective today 01/25/23 KAYAK and Affirm partner to help travelers book now and pay over time AFRM Affirm $15.99 / -1.22 (-7.09%) 02/01/23 Deutsche Bank Affirm price target raised to $18 from $11 at Deutsche Bank 01/23/23 Mizuho Affirm December securitization trends 'largely encouraging,' says Mizuho 01/20/23 DA Davidson Affirm price target lowered to $24 from $32 at DA Davidson 12/20/22 Deutsche Bank Affirm price target lowered to $11 from $14 at Deutsche Bank AFRM Affirm $15.99 / -1.22 (-7.09%) 16:15 Today Affirm sees FY23 revenue $1.475B-$1.55B, consensus $1.64B 16:14 Today Affirm sees Q3 revenue $360M-$380M, consensus $417.96M 16:12 Today Affirm reports Q2 EPS ($1.10), consensus (98c) 12:48 Today Notable companies reporting after market close AFRM Affirm $15.99 / -1.22 (-7.09%) 12/08/22 Walmart to back Buy-Now-Pay-Later loan fintech venture, The Information reports 09/15/22 CFPB to begin regulating 'buy-now, pay-later' firms, Reuters reports 09/14/22 Walmart-backed One to test checking accounts for workers, shoppers, Reuters says 08/13/22 Affirm CEO says next recession will silence doubters, WSJ reports AFRM Affirm $15.99 / -1.22 (-7.09%) 11/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/18/22 Sell these stocks now, proven algorithm says 11/09/22 What You Missed On Wall Street On Wednesday 11/09/22 What You Missed On Wall Street This Morning 17:00 Today Affirm - AFRM AFRM Affirm $15.99 / -1.22 (-7.09%) 13:19 Today Affirm Holdings options imply 18.3% move in share price post-earnings 01/20/23 Affirm Holdings call volume above normal and directionally bullish 01/19/23 Affirm Holdings put volume heavy and directionally bearish 01/11/23 Affirm Holdings call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

FORM
Today at 16:25

FormFactor - FORM Conference Calls
ME
Today at 16:30

23andMe - ME Conference Calls
TTMI
Today at 16:30

TTM Technologies - TTMI Conference Calls
DIS
Today at 16:30

Disney - DIS Conference Calls
VKTX
Today at 16:30

Viking Therapeutics - VKTX Conference Calls
AEIS
Today at 16:30

Advanced Energy - AEIS Conference Calls
INFA
Today at 16:30

Informatica - INFA Conference Calls
VNDA
Today at 16:30

Vanda Pharmaceuticals - VNDA Conference Calls
ASGN
Today at 16:30

ASGN - ASGN Conference Calls
RPD
Today at 16:30

Rapid7 - RPD Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BLNK X BLNK Blink Charging Spot Secondary Managers: Barclays Priced at: $12.00 8.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	CVAC X CVAC CureVac Secondary Managers: Goldman Sachs, Jefferies, SVB Securities & Kempen Priced at: $9.25 27.027M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DT X DT Dynatrace Spot Secondary Managers: BofA Priced at: $45.55 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan, Goldman Sachs & Morgan Stanley Priced at: $140.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LBPH X LBPH Longboard Pharmaceuticals Spot Secondary Managers: Evercore ISI & Cantor Fitzgerald Priced at: $4.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXST X RXST RxSight Spot Secondary Managers: BofA Priced at: $12.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SINT X SINT Sintx Technologies Spot Secondary Managers: Maxim Priced at: $5.60 2.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STAF X STAF Staffing 360 Solutions Spot Secondary Managers: H.C. Wainwright Priced at: $2.65 1.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical Spot Secondary Managers: BTIG Priced at: $21.00 4.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XPOF X XPOF Xponential Fitness Spot Secondary Managers: BofA & Jefferies Priced at: $24.50 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SONN X SONN Sonnet BioTherapeutics Secondary Managers: Chardan & EF Hutton Priced at: $1.08 13.89M Shares
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	BFRG X BFRG Bullfrog AI IPO Managers: WallachBeth, Kingswood $6.50 1.32M Shares HSAI X HSAI Hesai IPO Managers: Goldman Sachs, Morgan Stanley & Credit Suisse, Huatai Securities $17.00 - 19.00 9M Shares INTS X INTS Intensity Therapeutics IPO Managers: Benchmark $4.00-4.50 1.778M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRXS X NRXS Neuraxis IPO Managers: Alexander Capital $7.00-9.00 1.875M Shares NXT X NXT Nextracker IPO Managers: JPMorgan, BofA, Citi & Barclays, Truist, HSBC, BNP Paribas, Mizuho, Scotiabank, KeyBanc $20.00-23.00 23.26M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ENLT X ENLT Enlight Renewable Energy IPO Managers: JPMorgan, BofA & Barclays, Credit Suisse, Wolfe Research, Nomura, HSBC, Roth MKM $20.57 14M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LEWY X LEWY LeeWay Services IPO Managers: ThinkEquity $5.00 1M Shares MLYS X MLYS Mineralys Therapeutics IPO Managers: BofA, Ever Bank, Stifel, Credit Suisse, Guggenheim & Wells Fargo $14.00-16.00 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access